EE05343B1 - Tiotroopiumsoola sisaldav inhaleeritav lahusekompositsioon - Google Patents

Tiotroopiumsoola sisaldav inhaleeritav lahusekompositsioon

Info

Publication number
EE05343B1
EE05343B1 EEP200300202A EEP200300202A EE05343B1 EE 05343 B1 EE05343 B1 EE 05343B1 EE P200300202 A EEP200300202 A EE P200300202A EE P200300202 A EEP200300202 A EE P200300202A EE 05343 B1 EE05343 B1 EE 05343B1
Authority
EE
Estonia
Prior art keywords
composition containing
solution composition
tiotropium salt
inhalable solution
inhalable
Prior art date
Application number
EEP200300202A
Other languages
English (en)
Inventor
Drechsel Karin
Niklaus-Humke Barbara
Schmelzer Christel
Barth Petra
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7661727&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE05343(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma Gmbh & Co. Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co. Kg
Publication of EE200300202A publication Critical patent/EE200300202A/et
Publication of EE05343B1 publication Critical patent/EE05343B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, ***e
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
EEP200300202A 2000-10-31 2001-10-24 Tiotroopiumsoola sisaldav inhaleeritav lahusekompositsioon EE05343B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10054042 2000-10-31
PCT/EP2001/012296 WO2002036591A2 (de) 2000-10-31 2001-10-24 Inhalative lösungsformulierung mit einem tiotropiumsalz

Publications (2)

Publication Number Publication Date
EE200300202A EE200300202A (et) 2003-10-15
EE05343B1 true EE05343B1 (et) 2010-10-15

Family

ID=7661727

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300202A EE05343B1 (et) 2000-10-31 2001-10-24 Tiotroopiumsoola sisaldav inhaleeritav lahusekompositsioon

Country Status (33)

Country Link
EP (1) EP1335729A2 (et)
JP (1) JP4559703B2 (et)
KR (1) KR100983208B1 (et)
CN (1) CN1237970C (et)
AR (1) AR038765A1 (et)
AU (2) AU2174102A (et)
BG (1) BG66425B1 (et)
BR (1) BR0115016A (et)
CA (1) CA2427583C (et)
CZ (1) CZ305033B6 (et)
DE (1) DE10152369A1 (et)
EA (1) EA009068B1 (et)
EC (1) ECSP034570A (et)
EE (1) EE05343B1 (et)
HK (1) HK1060569A1 (et)
HR (1) HRP20030337A2 (et)
HU (1) HUP0301377A3 (et)
IL (2) IL155676A0 (et)
ME (1) ME00242B (et)
MX (1) MXPA03003750A (et)
MY (1) MY132777A (et)
NO (1) NO332524B1 (et)
NZ (1) NZ526024A (et)
PE (1) PE20020518A1 (et)
PL (1) PL361001A1 (et)
SA (1) SA01220503B1 (et)
SK (1) SK288031B6 (et)
TW (1) TWI296934B (et)
UA (1) UA76435C2 (et)
UY (1) UY26991A1 (et)
WO (1) WO2002036591A2 (et)
YU (1) YU33103A (et)
ZA (1) ZA200303045B (et)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA02010565A (es) 2000-04-28 2004-05-17 Kosan Biosciences Inc Produccion de policetidos.
US20030235538A1 (en) 2002-04-09 2003-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for the administration of an anticholinergic by inhalation
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
WO2005034871A2 (en) * 2003-10-09 2005-04-21 Inverseon, Inc. Methods for treating diseases and conditions with inverse agonists
SE0303269L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Medicinsk produkt
JP4991693B2 (ja) * 2005-03-16 2012-08-01 メダ ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト 呼吸器疾患の治療のための抗コリン作用薬及びロイコトリエン受容体アンタゴニストの組み合わせ剤
WO2007140285A2 (en) * 2006-05-26 2007-12-06 Dey, L.P. Nebulizable compositions of quaternary ammonium muscarinic receptor antagonists
CN100446770C (zh) * 2007-01-10 2008-12-31 上海现代药物制剂工程研究中心有限公司 丙酸培氯米松水雾剂
TR200907237A2 (tr) * 2009-09-23 2011-04-21 Bi̇lgi̇ç Mahmut Tiotropyum kuru toz kombinasyonu
CN116196298A (zh) * 2018-07-26 2023-06-02 四川海思科制药有限公司 一种含格隆铵盐的气雾剂药物组合物及其制备方法与应用
CN111936124A (zh) * 2018-07-26 2020-11-13 四川海思科制药有限公司 一种含格隆铵盐及茚达特罗盐的气雾剂药物组合物及其制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
DE4203306A1 (de) * 1992-02-06 1993-08-12 Ig Spruehtechnik Gmbh Asthma oder pulmonal-aerosolzubereitungen mit lecithin
UA62917C2 (en) * 1995-06-27 2004-01-15 Berinher Inhelheim Kg Medicinal composition for generating propellant-free aerosols
US5824669A (en) * 1996-03-22 1998-10-20 Nitromed, Inc. Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
EP0954318A1 (en) * 1996-06-04 1999-11-10 The Procter & Gamble Company A nasal spray containing an intranasal steroid and an antihistamine
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
JPH10298107A (ja) * 1997-04-25 1998-11-10 Taisho Pharmaceut Co Ltd 医薬組成物
US6475467B1 (en) * 1998-08-04 2002-11-05 Jago Research Ag Medicinal aerosol formulations
DE19847968A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Verschlußkappe und Behälter als Zweikammer-Kartusche für Vernebler zur Erzeugung von Aerosolen

Also Published As

Publication number Publication date
KR100983208B1 (ko) 2010-09-20
IL155676A0 (en) 2003-11-23
SA01220503B1 (ar) 2007-03-10
PL361001A1 (en) 2004-09-20
TWI296934B (en) 2008-05-21
EA200300483A1 (ru) 2003-12-25
JP4559703B2 (ja) 2010-10-13
BG107726A (bg) 2004-11-30
EP1335729A2 (de) 2003-08-20
MY132777A (en) 2007-10-31
EE200300202A (et) 2003-10-15
CA2427583A1 (en) 2002-05-10
HUP0301377A2 (hu) 2003-10-28
HK1060569A1 (en) 2004-08-13
NO20031914D0 (no) 2003-04-29
ZA200303045B (en) 2004-04-22
EA009068B1 (ru) 2007-10-26
HUP0301377A3 (en) 2005-12-28
ME00242B (me) 2011-05-10
NZ526024A (en) 2005-10-28
KR20040010552A (ko) 2004-01-31
DE10152369A1 (de) 2002-05-08
CZ305033B6 (cs) 2015-04-08
UY26991A1 (es) 2002-06-20
AU2002221741B2 (en) 2007-04-05
AR038765A1 (es) 2005-01-26
CN1237970C (zh) 2006-01-25
UA76435C2 (en) 2006-08-15
ECSP034570A (es) 2003-06-25
MEP40708A (en) 2011-02-10
SK5262003A3 (en) 2003-10-07
WO2002036591A2 (de) 2002-05-10
SK288031B6 (sk) 2012-12-03
CN1473044A (zh) 2004-02-04
BR0115016A (pt) 2005-05-03
JP2004523482A (ja) 2004-08-05
CA2427583C (en) 2008-02-12
PE20020518A1 (es) 2002-07-12
BG66425B1 (bg) 2014-04-30
YU33103A (sh) 2006-05-25
NO332524B1 (no) 2012-10-08
IL155676A (en) 2012-05-31
CZ20031487A3 (cs) 2003-09-17
HRP20030337A2 (en) 2005-04-30
NO20031914L (no) 2003-06-23
WO2002036591A3 (de) 2002-07-25
MXPA03003750A (es) 2004-10-15
AU2174102A (en) 2002-05-15

Similar Documents

Publication Publication Date Title
DE60020343D1 (de) Cilostazol enthaltende zubereitung
ATE275391T1 (de) Neue tiotropium-haltige inhalationspulver
DE60135560D1 (de) Valsartan salze
NO20022922L (no) Inhalasjonsanordning
IS7236A (is) Meðferðarfræðileg ísókínólínefnasambönd
NO20032909D0 (no) Glukopyranosyloksypyrazolderivater samt medikamentell anvendelse derav
NO20025450L (no) Ny farmasöytisk sammensetning
EE200200656A (et) Ravis kasutatavad tropaani derivaadid
ATE313952T1 (de) Stabile biozidale zusammensetzung
EE05020B1 (et) Glburiidi ravimkoostis
HK1129111A1 (en) Tiotropium salts, pharmaceutical formulations containing the salts and the use thereof
DK1299095T3 (da) Klart vandigt anæstetisk præparat
NO20022921D0 (no) Inhalasjonsanordning
ATE324883T1 (de) Pharmazeutische zusammensetzung enthaltend lumiracoxib
EE05343B1 (et) Tiotroopiumsoola sisaldav inhaleeritav lahusekompositsioon
ATE350016T1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
EE200300203A (et) Tiotroopiumsoola sisaldav inhaleeritav lahusekompositsioon
PT1227817E (pt) Composicao farmaceutica aquosa contendo ciclesonida
ATE304289T1 (de) Fungizide zusammensetzungen enthaltend fludioxonil
ATE297187T1 (de) Resorcinenthaltende zusammensetzung
DE60124516D1 (de) Kombination des lezithins mit ascorbinsäure
ATE350029T1 (de) Pharmazeutische zusammensetzung enthaltend gamma- butyrobetain
EE200300045A (et) Kristalne ravimaine
SE0004749D0 (sv) New salt form
ES1046338Y (es) Salero pefeccionado

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20101231